Squamous cell carcinoma (SCC) is the second most frequent form of skin cancer after basal cell carcinoma. While most SCC can be treated by surgery or radiotherapy, some progress into an advanced form and are no longer suitable for these treatments. Guidelines and staging systems have help to define these advanced SCC (aSCC), for which prognosis was very poor until recently. Platin-based chemotherapy was traditionally used, but few prospective trials and no treatment regimen was recommended. Furthermore, toxicity in elderly patients limited its use. The development of immunotherapy has improved the prognosis of these difficult-to-treat aSCC. In this review, we define high risk and aSCC and explored current treatment strategies for these tumors.
CITATION STYLE
Basset-Seguin, N., & Maubec, E. (2022). Recent Advanced in the Treatment of Advanced SCC Tumors. Cancers, 14(3). https://doi.org/10.3390/cancers14030550
Mendeley helps you to discover research relevant for your work.